ID25446A - Bentuk stabil secara termodinamika dari asam (r)-3-((4-fluora)sulfonil) amino-1,2,3,4-tetrahidro-9h-karbazol-9-propanoat (ramatroban) - Google Patents

Bentuk stabil secara termodinamika dari asam (r)-3-((4-fluora)sulfonil) amino-1,2,3,4-tetrahidro-9h-karbazol-9-propanoat (ramatroban)

Info

Publication number
ID25446A
ID25446A IDW20001226A ID20001226A ID25446A ID 25446 A ID25446 A ID 25446A ID W20001226 A IDW20001226 A ID W20001226A ID 20001226 A ID20001226 A ID 20001226A ID 25446 A ID25446 A ID 25446A
Authority
ID
Indonesia
Prior art keywords
termodynamics
karbazol
propanoat
tetrahidro
sulfonil
Prior art date
Application number
IDW20001226A
Other languages
English (en)
Indonesian (id)
Inventor
Alfons Grunenberg
Karl-Heinz Wahl
Klaus Pewter Voges
Original Assignee
Bayer Yakuhin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin Ltd filed Critical Bayer Yakuhin Ltd
Publication of ID25446A publication Critical patent/ID25446A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IDW20001226A 1997-12-24 1998-12-24 Bentuk stabil secara termodinamika dari asam (r)-3-((4-fluora)sulfonil) amino-1,2,3,4-tetrahidro-9h-karbazol-9-propanoat (ramatroban) ID25446A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)

Publications (1)

Publication Number Publication Date
ID25446A true ID25446A (id) 2000-10-05

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001226A ID25446A (id) 1997-12-24 1998-12-24 Bentuk stabil secara termodinamika dari asam (r)-3-((4-fluora)sulfonil) amino-1,2,3,4-tetrahidro-9h-karbazol-9-propanoat (ramatroban)

Country Status (36)

Country Link
US (1) US6362214B1 (en:Method)
EP (1) EP1051398B1 (en:Method)
JP (2) JP3817668B2 (en:Method)
KR (1) KR100586350B1 (en:Method)
CN (1) CN1140510C (en:Method)
AR (1) AR013803A1 (en:Method)
AT (1) ATE263152T1 (en:Method)
AU (1) AU744242B2 (en:Method)
BG (1) BG65024B1 (en:Method)
BR (1) BR9814496A (en:Method)
CA (1) CA2313230A1 (en:Method)
CO (1) CO4970800A1 (en:Method)
DE (2) DE19757983A1 (en:Method)
DK (1) DK1051398T3 (en:Method)
ES (1) ES2218874T3 (en:Method)
GT (1) GT199800198A (en:Method)
HN (1) HN1998000186A (en:Method)
HU (1) HUP0004432A3 (en:Method)
ID (1) ID25446A (en:Method)
IL (1) IL136278A (en:Method)
IN (1) IN192932B (en:Method)
MY (1) MY116312A (en:Method)
NO (1) NO316618B1 (en:Method)
NZ (1) NZ504741A (en:Method)
PE (1) PE20000115A1 (en:Method)
PL (1) PL341359A1 (en:Method)
PT (1) PT1051398E (en:Method)
RU (1) RU2220137C2 (en:Method)
SI (1) SI1051398T1 (en:Method)
SK (1) SK285109B6 (en:Method)
TR (1) TR200001936T2 (en:Method)
TW (1) TW552258B (en:Method)
UA (1) UA66832C2 (en:Method)
UY (2) UY25324A1 (en:Method)
WO (1) WO1999033803A1 (en:Method)
ZA (1) ZA9811817B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395120T3 (es) * 2006-12-20 2013-02-08 Cardoz Ab Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios
CA2675520A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂
US20180021302A1 (en) 2015-02-13 2018-01-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557665A (en) * 1975-12-10 1979-12-12 Ici Ltd Process for the manufacture of a carboxyalkylamino anthraquinone compounds
US4616028A (en) * 1985-04-22 1986-10-07 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use
CN1015711B (zh) 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1，2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
DE19506739A1 (de) 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
PT1051398E (pt) 2004-07-30
KR100586350B1 (ko) 2006-06-07
SK285109B6 (sk) 2006-06-01
AU1687499A (en) 1999-07-19
TW552258B (en) 2003-09-11
KR20010033529A (ko) 2001-04-25
UA66832C2 (uk) 2004-06-15
EP1051398A1 (en) 2000-11-15
TR200001936T2 (tr) 2001-01-22
JP2001527067A (ja) 2001-12-25
DE69822882D1 (en) 2004-05-06
HUP0004432A3 (en) 2002-10-28
WO1999033803A1 (en) 1999-07-08
BR9814496A (pt) 2000-10-10
DE19757983A1 (de) 1999-07-01
CO4970800A1 (es) 2000-11-07
ZA9811817B (en) 1999-06-29
PE20000115A1 (es) 2000-03-26
DK1051398T3 (da) 2004-07-19
MY116312A (en) 2003-12-31
CN1282320A (zh) 2001-01-31
CN1140510C (zh) 2004-03-03
UY25324A1 (es) 2000-12-29
HN1998000186A (es) 1999-11-03
NO20003217D0 (no) 2000-06-21
IL136278A0 (en) 2001-05-20
IN192932B (en:Method) 2004-06-12
ATE263152T1 (de) 2004-04-15
NO20003217L (no) 2000-06-21
AR013803A1 (es) 2001-01-10
IL136278A (en) 2005-03-20
NZ504741A (en) 2002-10-25
JP3817668B2 (ja) 2006-09-06
AU744242B2 (en) 2002-02-21
BG65024B1 (bg) 2006-12-29
NO316618B1 (no) 2004-03-08
US6362214B1 (en) 2002-03-26
BG104554A (en) 2001-05-31
CA2313230A1 (en) 1999-07-08
ES2218874T3 (es) 2004-11-16
DE69822882T2 (de) 2005-02-03
HK1034517A1 (en) 2001-10-26
HUP0004432A2 (hu) 2001-06-28
SI1051398T1 (en) 2004-08-31
JP2006151977A (ja) 2006-06-15
RU2220137C2 (ru) 2003-12-27
GT199800198A (es) 1998-12-15
SK9752000A3 (en) 2001-02-12
JP4411269B2 (ja) 2010-02-10
EP1051398B1 (en) 2004-03-31
UY25575A1 (es) 1999-11-17
PL341359A1 (en) 2001-04-09

Similar Documents

Publication Publication Date Title
ID24626A (id) Turunan-turunan asam hidroksamat sebagai penghambat metaloprotease matriks (mmp)
DK1084103T3 (da) Nyt 3-aryl-2-hydroxpropionsyrederivat (I)
ID26222A (id) Hidroksamida asam(4-arilsulfonilamino)-tetrahidropiran-4-karboksilat
ID20809A (id) Asam diaminokarboksilat tersubstitusi
PT925298E (pt) Derivados 6,6-hetero-biciclicos substituidos
ID20807A (id) Asam sulfonilaminokarboksilat
ZA981061B (en) Arylsulfonyl hydroxamic acid derivatives.
NO995635D0 (no) 3(5)-heteroaryl-substituerte pyrazoler som p38-kinaseinhibitorer
IS5340A (is) Arýloxýarýlsúlfónýlamínó hýdroxamsýru afleiður
TNSN96165A1 (fr) Nouveaux pesticides.
TR199802289A3 (tr) Fosfonasit-ikame etmis benzazepinon-n-asetikasit türevleri.
AU8860898A (en) Substituted n-aryl-n-thioxocarbonyl sulfonamides as herbicides
DE69812371D1 (de) Phenyllacrylsäurederivate enthaltende fungizide kombinationen
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
DE69823394D1 (de) Verfahren zur Herstellung von 1-(9'H-Carbazol-4'-yloxy)-3-(2''-(2'''-methoxy-phenoxy)-ethylamino)-propan-2-ol ( Carvediol)
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
IT1318457B1 (it) Cartuccia per la perforazione dell'orecchio.
ID25446A (id) Bentuk stabil secara termodinamika dari asam (r)-3-((4-fluora)sulfonil) amino-1,2,3,4-tetrahidro-9h-karbazol-9-propanoat (ramatroban)
ID28810A (id) Senyawa-senyawa amida-omega asam n-arilsulfonilamino
DE69905162D1 (de) 3-[2-oxo-(1,3')bipyrrolidinyl-3-yliden-methyl]-cephemderivate
IL127469A0 (en) Modified form of the R (-)-N-(4,4-DI(3-methylthien-s-yl) but-3-enyl)-nipecotic acid hydrochloride
IT1296094B1 (it) Suoletto di montaggio per l'assemblaggio di calzature, calzatura assemblata sul suoletto e procedimento di preparazione
FR2793151B3 (fr) Plateau d'equilibre
AU8985298A (en) Novel sulphonamide derived from substituted anilines useful as medicines